Invention Grant
US08877190B2 Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
有权
A＆bgr 构象异构选择性抗A＆bgr; 球聚体单克隆抗体
- Patent Title: Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
- Patent Title (中): A＆bgr 构象异构选择性抗A＆bgr; 球聚体单克隆抗体
-
Application No.: US13102713Application Date: 2011-05-06
-
Publication No.: US08877190B2Publication Date: 2014-11-04
- Inventor: Stefan Barghorn , Heinz Hillen , Andreas R. Striebinger , Boris Labkovsky , Ulrich Ebert , Patrick Keller
- Applicant: Stefan Barghorn , Heinz Hillen , Andreas R. Striebinger , Boris Labkovsky , Ulrich Ebert , Patrick Keller
- Applicant Address: US IL North Chicago DE Wiesbaden
- Assignee: AbbVie Inc.,AbbVie Deutschland GmbH & Co. KG
- Current Assignee: AbbVie Inc.,AbbVie Deutschland GmbH & Co. KG
- Current Assignee Address: US IL North Chicago DE Wiesbaden
- Agency: Michael Best & Friedrich LLP
- Agent Lisa V. Mueller
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/18
Abstract:
The subject invention relates to monoclonal antibodies that may be used in the treatment and diagnosis of Alzheimer's Disease. In particular, the present invention relates to monoclonal antibodies referred to as 10F4 and 3C5 and to other monoclonal antibodies (e.g., murine, human or humanized) having similar properties thereto.
Public/Granted literature
- US20110212109A1 Abeta CONFORMER SELECTIVE ANTI-Abeta GLOBULOMER MONOCLONAL ANTIBODIES Public/Granted day:2011-09-01
Information query
